SAN DIEGO -- September 14, 2010 -- Angiotensin converting enzyme inhibitors (ACEI) are not associated with an increased, or decreased, incidence of gastrointestinal (GI) cancer or other cancers, according to a study presented here September 13 at the 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA).
